Detection of PEG-specific antibodies in SARS-CoV-2 positive and negative sera with implications for autoimmune reactivity. [PDF]
Vojdani A, Vojdani E.
europepmc +1 more source
A Procedure Which Eliminates Nonspecific Inhibitor from Human Serum But does not Affect Specific Antibodies Against Influenza Viruses [PDF]
D. A. J. Tyrrell, Frank L. Horsfall
openalex +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira+14 more
wiley +1 more source
Unexpected occurrence of anti-B antibodies in a patient with A2B blood group: a case report and review of literature. [PDF]
Kalhori F, Babakhani M, Sayyadi M.
europepmc +1 more source
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian+10 more
wiley +1 more source
Phospholipids and phospholipase A1 as antigens during the course of experimental Trypanosoma cruzi infection. [PDF]
Bott E+4 more
europepmc +1 more source
The conglutination phenomenon: IV. The importance of the choice of complement when examining antisera for the presence of complement-fixing or complement-absorbing antibodies [PDF]
R.R.A. Coombs, N. H. Hole
openalex +1 more source
We investigated whether hypomethylating agents (HMAs) used in myeloid malignancies induce somatic retrotransposition. Our findings indicate that HMA treatment increases L1‐encoded protein expression but does not lead to detectable de novo retrotransposition events in either patient samples or cell lines.
Šárka Pavlová+14 more
wiley +1 more source
Monoclonal Antibodies: Historical Perspective and Current Trends in Biological Drug Development. [PDF]
Madej B+5 more
europepmc +1 more source